- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-3-3-3-mer
- Ligands
- 15 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
- 16 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.16: 1 residues within 4Å:- Chain G: N.603
Ligand excluded by PLIPNAG.17: 1 residues within 4Å:- Chain G: N.616
Ligand excluded by PLIPNAG.18: 3 residues within 4Å:- Chain G: H.655, V.656, N.657
Ligand excluded by PLIPNAG.19: 3 residues within 4Å:- Chain G: N.709, G.1131
- Chain I: D.796
Ligand excluded by PLIPNAG.20: 3 residues within 4Å:- Chain G: A.706, E.1072, N.1074
Ligand excluded by PLIPNAG.21: 1 residues within 4Å:- Chain H: N.61
Ligand excluded by PLIPNAG.22: 2 residues within 4Å:- Chain H: N.603, T.604
Ligand excluded by PLIPNAG.23: 1 residues within 4Å:- Chain H: N.616
Ligand excluded by PLIPNAG.24: 3 residues within 4Å:- Chain H: H.655, V.656, N.657
Ligand excluded by PLIPNAG.25: 3 residues within 4Å:- Chain G: D.796
- Chain H: N.709, G.1131
Ligand excluded by PLIPNAG.26: 3 residues within 4Å:- Chain H: A.706, E.1072, N.1074
Ligand excluded by PLIPNAG.27: 2 residues within 4Å:- Chain I: N.603, T.604
Ligand excluded by PLIPNAG.28: 1 residues within 4Å:- Chain I: N.616
Ligand excluded by PLIPNAG.29: 3 residues within 4Å:- Chain I: H.655, V.656, N.657
Ligand excluded by PLIPNAG.30: 3 residues within 4Å:- Chain H: D.796
- Chain I: N.709, G.1131
Ligand excluded by PLIPNAG.31: 3 residues within 4Å:- Chain I: A.706, E.1072, N.1074
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Wang, N. et al., Structure-based development of human antibody cocktails against SARS-CoV-2. Cell Res. (2021)
- Release Date
- 2020-12-16
- Peptides
- heavy chain of FC05 Fab: ACE
light chain of FC05 Fab: BDF
Spike glycoprotein: GHI
heavy chain of P17 Fab: JLN
light chain of P17 Fab: KMO - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
PC
NE
JB
ID
GF
FG
BH
CI
AJ
HL
MN
OK
LM
RO
S
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-3-3-3-mer
- Ligands
- 15 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
- 16 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Wang, N. et al., Structure-based development of human antibody cocktails against SARS-CoV-2. Cell Res. (2021)
- Release Date
- 2020-12-16
- Peptides
- heavy chain of FC05 Fab: ACE
light chain of FC05 Fab: BDF
Spike glycoprotein: GHI
heavy chain of P17 Fab: JLN
light chain of P17 Fab: KMO - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
PC
NE
JB
ID
GF
FG
BH
CI
AJ
HL
MN
OK
LM
RO
S